Endocytoscopic intramucosal capillary network changes and crypt architecture abnormalities can predict relapse in patients with an ulcerative colitis Mayo endoscopic score of 1.
biopsy
capillaries
endoscopy
histological
mucosa
Journal
Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society
ISSN: 1443-1661
Titre abrégé: Dig Endosc
Pays: Australia
ID NLM: 9101419
Informations de publication
Date de publication:
Nov 2020
Nov 2020
Historique:
received:
23
12
2019
revised:
10
02
2020
accepted:
17
02
2020
pubmed:
20
2
2020
medline:
29
7
2021
entrez:
20
2
2020
Statut:
ppublish
Résumé
Recent studies have suggested the necessity of therapeutic intervention for patients with ulcerative colitis at high risk of clinical relapse with a Mayo endoscopic score (MES) of 1. The aim of this retrospective cohort study was to demonstrate the impact of intramucosal capillary network changes and crypt architecture abnormalities to stratify the risk of relapse in patients with an MES of 1. All included patients had an MES of ≤1 and confirmed sustained clinical remission between October 2016 and April 2019. We classified patients with an MES of 1 as "intramucosal capillary/crypt (ICC)-active" or "ICC-inactive" using endocytoscopic evaluation. We followed patients until October 2019 or until relapse; the main outcome measure was the difference in clinical relapse-free rates between ICC-active and ICC-inactive patients with an MES of 1. We included 224 patients and analyzed data for 218 (82 ICC-active and 54 ICC-active with an MES of 1 and 82 with an MES of 0). During follow-up, among the patients with an MES of 1, 30.5% (95% confidence interval 20.8-41.6; 25/82) of the patients relapsed in the ICC-active group and 5.6% (95% confidence interval 1.2-15.4; 3/54) of the patients relapsed in the ICC-inactive group. The ICC-inactive group had a significantly higher clinical relapse-free rate compared with the ICC-active group (P < 0.01). In vivo intramucosal capillary network and crypt architecture patterns stratified the risk of clinical relapse in patients with an MES of 1 (UMIN 000032580; UMIN 000036359).
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1082-1091Informations de copyright
© 2020 Japan Gastroenterological Endoscopy Society.
Références
Neurath MF, Travis SP. Mucosal healing in inflammatory bowel diseases: A systematic review. Gut. 2012; 61: 1619-35.
Colombel JF, Rutgeerts P, Reinisch W et al. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology. 2011; 141: 1194-201.
Samaan MA, Mosli MH, Sandborn WJ et al. A systematic review of the measurement of endoscopic healing in ulcerative colitis clinical trials: Recommendations and implications for future research. Inflamm. Bowel Dis. 2014; 20: 1465-71.
Barreiro-de Acosta M, Vallejo N, de la Iglesia D et al. Evaluation of the risk of relapse in ulcerative colitis according to the degree of mucosal healing (Mayo 0 vs 1): A longitudinal cohort study. J. Crohn's Colitis 2016; 10: 13-9.
Fukuda T, Naganuma M, Sugimoto S et al. Efficacy of therapeutic intervention for patients with an ulcerative colitis Mayo endoscopic score of 1. Inflamm. Bowel Dis. 2019; 25: 782-8.
Kudo SE, Misawa M, Wada Y et al. Endocytoscopic microvasculature evaluation is a reliable new diagnostic method for colorectal lesions (with video). Gastrointest. Endosc. 2015; 82: 912-3.
Misawa M, Kudo SE, Mori Y et al. Characterization of colorectal lesions using a computer-aided diagnostic system for narrow-band imaging endocytoscopy. Gastroenterology. 2016; 150: 1531-2.e3.
Mori Y, Kudo SE, Misawa M et al. Real-time use of artificial intelligence in identification of diminutive polyps during colonoscopy: a prospective study. Ann. Intern. Med. 2018; 169: 357-66.
Maeda Y, Ohtsuka K, Kudo SE et al. Endocytoscopic narrow-band imaging efficiency for evaluation of inflammatory activity in ulcerative colitis. World J. Gastroenterol. 2015; 21: 2108-15.
Nakazato Y, Naganuma M, Sugimoto S et al. Endocytoscopy can be used to assess histological healing in ulcerative colitis. Endoscopy 2017; 49: 560-3.
Ueda N, Isomoto H, Ikebuchi Y et al. Endocytoscopic classification can be predictive for relapse in ulcerative colitis. Medicine (Baltimore) 2018; 97: 107-12.
Schroeder KW, Tremaine WJ, Ilstrup DM et al. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N. Engl. J. Med. 1987; 317: 1625-9.
Travis SP, Schnell D, Krzeski P et al. Developing an instrument to assess the endoscopic severity of ulcerative colitis: The Ulcerative Colitis Endoscopic Index of Severity (UCEIS). Gut 2012; 61: 535-42.
Geboes K, Riddell R, Öst A et al. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut 2000; 47: 404-9.
Bessissow T, Lemmens B, Ferrante M et al. Prognostic value of serologic and histologic markers on clinical relapse in ulcerative colitis patients with mucosal healing. Am. J. Gastroenterol. 2012; 107: 1684-92.
Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-74.
Li CQ, Xie XJ, Yu T et al. Classification of inflammation activity in ulcerative colitis by confocal laser endomicroscopy. Am. J. Gastroenterol. 2010; 105: 1391-6.
Buda A, Hatem G, Neumann H et al. Confocal laser endomicroscopy for prediction of disease relapse in ulcerative colitis: A pilot study. J. Crohn's Colitis 2014; 8: 304-11.
Iacucci M, Fort Gasia M, Hassan C et al. Complete mucosal healing defined by endoscopic Mayo subscore still demonstrates abnormalities by novel high definition colonoscopy and refined histological gradings. Endoscopy 2015; 47: 726-34.
Iacucci M, Kiesslich R, Gui X et al. Beyond white light: Optical enhancement in conjunction with magnification colonoscopy for the assessment of mucosal healing in ulcerative colitis. Endoscopy 2017; 49: 553-9.
Esaki M, Kubokura N, Kudo T et al. Endoscopic findings under narrow band imaging colonoscopy in ulcerative colitis. Dig. Endosc. 2011; 23(Suppl 1): 140-2.
Sasanuma S, Ohtsuka K, Kudo SE et al. Narrow band imaging efficiency in evaluation of mucosal healing/relapse of ulcerative colitis. Endosc. Int. Open 2018; 6: E518-23.
Sivanathan V, Tontini G, Möhler M et al. Advanced endoscopic imaging for diagnosis of inflammatory bowel diseases: Present and future perspectives. Dig. Endosc. 2018; 30: 441-8.
Bryant RV, Burger DC, Delo J et al. Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up. Gut 2016; 65: 408-14.
Zenlea T, Yee EU, Rosenberg L et al. Histology grade is independently associated with relapse risk in patients with ulcerative colitis in clinical remission: a prospective study. Am. J. Gastroenterol. 2016; 111: 685-90.
Ozaki R, Kobayashi T, Okabayashi S et al. Histological risk factors to predict clinical relapse in ulcerative colitis with endoscopically normal mucosa. J. Crohn's Colitis 2018; 12: 1288-94.
Cushing K, Tan W, Alpers D et al. Complete histologic normalisation is associated with reduced risk of relapse among patients with ulcerative colitis in complete endoscopic remission. Aliment. Pharmacol. Ther. 2020; 51: 347-55.
Maeda Y, Kudo SE, Mori Y et al. Fully automated diagnostic system with artificial intelligence using endocytoscopy to identify the presence of histologic inflammation associated with ulcerative colitis (with video). Gastrointest. Endosc. 2019; 2: 408-15.
Bessho R, Kanai T, Hosoe N et al. Correlation between endocytoscopy and conventional histopathology in microstructural features of ulcerative colitis. J. Gastroenterol. 2011; 46: 1197-202.
Sano Y, Tanaka S, Kudo S et al. Narrow-band imaging (NBI) magnifying endoscopic classification of colorectal tumors proposed by the Japan NBI Expert Team. Dig. Endosc. 2016; 28: 526-33.
Kawasaki K, Nakamura S, Esaki M et al. Clinical usefulness of magnifying colonoscopy for the diagnosis of ulcerative colitis-associated neoplasia. Dig. Endosc. 2019; 31(Suppl 1): 36-42.
Gulati S, Dubois P, Carter B et al. A randomized crossover trial of conventional vs virtual chromoendoscopy for colitis surveillance: Dysplasia Detection, Feasibility, and Patient Acceptability (CONVINCE). Inflamm. Bowel Dis. 2019; 25(6): 1096-106.
Shergill AK, Lightdale JR, Bruining DH et al. The role of endoscopy in inflammatory bowel disease. Gastrointest. Endosc. 2015; 81: 1101-21.e13.
Nishiyama S, Oka S, Tanaka S et al. Clinical usefulness of endocytoscopy in the remission stage of ulcerative colitis: A pilot study. J. Gastroenterol. 2015; 50: 1087-93.